Symbols / ESPR Stock $1.91 -3.05% Esperion Therapeutics, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
ESPR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 491.64M Enterprise Value 886.06M Income -22.68M Sales 403.14M Book/sh -1.23 Cash/sh 0.65
Dividend Yield Payout 0.00% Employees 294 IPO P/E Forward P/E 7.88
PEG P/S 1.22 P/B -1.55 P/C EV/EBITDA 14.68 EV/Sales 2.20
Quick Ratio 1.02 Current Ratio 1.54 Debt/Eq LT Debt/Eq EPS (ttm) -0.11 EPS next Y 0.24
EPS Growth Revenue Growth 143.70% Earnings 2026-05-07 ROA 9.30% ROE ROIC
Gross Margin 56.07% Oper. Margin 50.60% Profit Margin -5.63% Shs Outstand 257.40M Shs Float 254.56M Short Float 12.95%
Short Ratio 5.86 Short Interest 52W High 4.18 52W Low 0.69 Beta 1.17 Avg Volume 5.58M
Volume 4.39M Target Price $6.99 Recom Buy Prev Close $1.97 Price $1.91 Change -3.05%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-3.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest ESPR news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-17 KOENIG SHELDON L Chief Executive Officer 25,578 $2.72 $69,547
2026-03-17 LOOKER BENJAMIN Officer 5,708 $2.70 $15,429
2026-03-17 HALLADAY BENJAMIN Chief Financial Officer 6,424 $2.70 $17,377
2026-03-13 KOENIG SHELDON L Chief Executive Officer 723,760 $0.00 $0
2026-03-13 LOOKER BENJAMIN Officer 300,840 $0.00 $0
2026-03-13 HALLADAY BENJAMIN Chief Financial Officer 247,430 $0.00 $0
2026-01-20 LOOKER BENJAMIN General Counsel 1,689 $2.88 $4,868
2025-12-17 KOENIG SHELDON L Chief Executive Officer 48,244 $3.67 $177,200
2025-12-17 LOOKER BENJAMIN General Counsel 6,517 $3.67 $23,898
2025-12-17 HALLADAY BENJAMIN Chief Financial Officer 7,337 $3.67 $26,905
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category